205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
12.28%
Revenue growth above 1.5x NXPI's 4.40%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
13.83%
Gross profit growth above 1.5x NXPI's 7.73%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
24.58%
EBIT growth below 50% of NXPI's 769.23%. Michael Burry would suspect deeper competitive or cost structure issues.
24.89%
Operating income growth under 50% of NXPI's 769.23%. Michael Burry would be concerned about deeper cost or sales issues.
18.19%
Net income growth under 50% of NXPI's 800.00%. Michael Burry would suspect the firm is falling well behind a key competitor.
23.46%
EPS growth under 50% of NXPI's 775.00%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
24.05%
Diluted EPS growth under 50% of NXPI's 782.41%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.22%
Share reduction while NXPI is at 3.34%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
0.10%
Diluted share reduction more than 1.5x NXPI's 0.90%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
0.22%
Dividend growth of 0.22% while NXPI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
32.18%
OCF growth under 50% of NXPI's 65.44%. Michael Burry might suspect questionable revenue recognition or rising costs.
39.85%
FCF growth 50-75% of NXPI's 71.35%. Martin Whitman would see if structural disadvantages exist in generating free cash.
46.99%
Similar 10Y revenue/share CAGR to NXPI's 46.93%. Walter Schloss might see both firms benefiting from the same long-term demand.
21.16%
5Y revenue/share CAGR under 50% of NXPI's 72.21%. Michael Burry would suspect a significant competitive gap or product weakness.
24.02%
3Y revenue/share CAGR at 50-75% of NXPI's 46.43%. Martin Whitman would question if the firm lags behind competitor innovations.
407.30%
10Y OCF/share CAGR under 50% of NXPI's 1002.29%. Michael Burry would worry about a persistent underperformance in cash creation.
41.89%
Below 50% of NXPI's 168.11%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
34.40%
3Y OCF/share CAGR under 50% of NXPI's 78.48%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
107.43%
Positive 10Y CAGR while NXPI is negative. John Neff might see a substantial advantage in bottom-line trajectory.
84.05%
Positive 5Y CAGR while NXPI is negative. John Neff might view this as a strong mid-term relative advantage.
68.48%
Positive short-term CAGR while NXPI is negative. John Neff would see a clear advantage in near-term profit trajectory.
28.66%
Equity/share CAGR of 28.66% while NXPI is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
6.60%
Below 50% of NXPI's 474.81%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
1.90%
Below 50% of NXPI's 550.18%. Michael Burry suspects a serious short-term disadvantage in building book value.
1149.23%
Dividend/share CAGR of 1149.23% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
194.94%
Dividend/share CAGR of 194.94% while NXPI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
35.78%
3Y dividend/share CAGR of 35.78% while NXPI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
7.34%
AR growth well above NXPI's 6.64%. Michael Burry fears inflated revenue or higher default risk in the near future.
-3.62%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
3.33%
Asset growth above 1.5x NXPI's 0.86%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
3.48%
Positive BV/share change while NXPI is negative. John Neff sees a clear edge over a competitor losing equity.
-0.03%
We’re deleveraging while NXPI stands at 5.49%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
3.52%
We increase R&D while NXPI cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
-2.64%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.